Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2006-07-28
2008-10-07
Mertz, Prema (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S141100, C424S145100, C424S001490
Reexamination Certificate
active
07431924
ABSTRACT:
Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
REFERENCES:
patent: 6013257 (2000-01-01), Pan
patent: 6043086 (2000-03-01), Pan
patent: 6548654 (2003-04-01), Hardiman et al.
patent: 6566503 (2003-05-01), Hardiman et al.
patent: WO97/42224 (1997-11-01), None
Mikayama et al. Proc. Natl. Acad. Sci. USAVol. 90, pp. 10056-10060.
Voet et al. Biochemistry John Wiley & Sons, Inc., pp. 126-128 and 228-234.
Kevin B. Bacon et al., Int. Arch. Allergy Immunol., 109:97-109, 1996. “Chemokines as Mediators of Allergic Inflammation”.
J. Fernando Bazan et al., Nature, 385:640-644, Feb. 13, 1997. A new class of membrane-bound chemokine with a CX3C motif.
D. Beier et al., Genbank Accession No. R75309, p. 1, Jun. 6, 1995.
Mark S. Boguski, Trends Biochem. Sci. (TIBS), 20:295-296, 1995. “The turning point in genome research”.
Myriam C. Capone et al., J. Immunol. 157:969-973, 1996. “Identification Through Bioinformatics of cDNAs Encoding Human Thymic Shared Ag-1/Stem Cell Ag-2: A New member of the Human Ly-6 Family.sup.1,2”.
Angela M. Gronenborn et al., Protein Engineering, 4(3):263-269, 1991. “Modeling the Three-Dimensional Structure of the Monocyte Chemo-Attractant and Activating Protein MCAF/MCP-1 on the Basis of the Solution Structure of Interleukin-8”.
L. Hillier et al., Genbank Accession No. H06104, pp. 1-2, Jun. 21, 1995.
Patricia J. Lodi et al., Science, 263:1762-1767, 1994. “High-Resolution Solution Structure of the .beta. Chemokine hMIP-1.beta. by Multidimensional NMR.”
Kouji Matsushima et al., Cytokine, 1(1):2-13, 1989. “Interleukin 8 and MCAF: Novel Inflammatory Cytokines Inducible by IL 1 and TNF”.
Michael D. Miller et al., Proc. Natl. Acad. Sci., 89:2950-2954, 1992. “The Human Cytokine I-309 is a Monocyte Chemoattractant”.
Joost J. Oppenheim et al., Annu. Rev. Immunol. 9:617-648, 1991. “Properties of the Novel Proinflammatory Supergene ‘Intercrine’ Cytokine Family”.
Thomas J. Schall, The Cytokine Handbook, Angus W. Thompson, Ed., 2nd ed. The Academic Press Limited, Ch. 22, pp. 419-460, 1994. “The Chemokines”.
Thomas J. Schall et al., Current Opinion in Immunol., 6:865-873, 1994. “Chemokines, Leukocyte Trafficking, and Inflammation”.
Thomas J. Schall, Cytokine, 3(3):165-183, 1991, “Biology of the RANTES/SIS Cytokine Family”.
Mark Y. Stoeckle et al., The New Biologist, 2(4):313-323, 1990. “Two Burgeoning Families of Platelet Factor 4-Related Proteins: Mediators of the Inflammatory Response”.
Steven R. Wiley et al., Immunity, 3: 673-682, 1995. “Identification and Characterization of a New Member of the TNF Family that Induces Apoptosis”.
D. Rossi et al., FASEB Journal, 10(6):A1049, Abstract No. 290, from Joint Meeting of the American Society for Biochemistry and Molecular Biology, The American Society for Investigative Pathology and the American Association of Immunologists, New Orleans, LA, USA Jun. 1996. “Identification of a .gamma. or “C” chemokine from the chicken and a novel human and mouse chemokine”.
L. Hillier et al., EMBL Database Entry HS940163, Accession No. H14940, Jul. 3, 1995, XP002030088. “The WashU-Merck EST project”.
C. Auffray et al., EMBL Database Entry HSC20F041, Accession No. Z44443, Sep. 21, 1995, XP002030091. “Image: Integrated molecular analysis of the human genome and its expression”.
Fiorenza Cocchi et al., Science, 270:1811-1815, Dec. 15, 1995. “Identification of RANTES, MIP-1.alpha., and MIP-1.beta. as the Major HIV-Suppressive Factors Produced by CD8.sup.+ T Cells”.
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W34307, citing: WO 9742224 A1 dated Nov. 13, 1997, US 97-851160 dated May 5, 1997; US 96-643798 dated May 7, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 19P-W23345, citing: WO 9727299 A1 dated Jul. 31, 1997; WO 97-US293 dated Jan. 23, 1997; US 96-649006; US 96-590828 dated Jan. 24, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W34308, citing: WO 9742224 A1 dated Nov. 13, 1997; WO 97-US7737 dated May 6, 1997; US 97-851160 dated May 5, 1997; US 96-643798 dated May 7, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 19P-W23347, citing: WO 9727299 A1 dated Jul. 31, 1997; WO 97-US293 dated Jan. 23, 1997; US 96-649006 dated May 16, 1996; US 96-590828 dated Jan. 24, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 19P-W23344, citing: WO 9727299 A1 dated Jul. 31, 1997; WO 97-US293 dated Jan. 23, 1997; US 96-6496006 dated Jan. 6, 1996; US 96-950828 dated Jan. 24, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 19P-W23346, citing: WO 9727299 A1 dated Jul. 31, 1997; WO 97-US293 dated Jan. 23, 1997; US 96-649006 dated May 16, 1996; US 96-590828 dated Jan. 24, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 98P-W42072, citing: WO 9802459 A1 dated Jan. 22, 1998; WO 97-US12349 dated Jul. 15, 1997; US 96-683655 dated Jul. 15, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W26655, citing: WO 9725427 A1 dated Jul. 17, 1997; WO 97-US379 dated Jan. 10, 1997; US 98-586395 dated Jan. 12, 1996; “Search record pertaining to human CX3C chemokine, performed in Jul. 1998”.
Derwent Geneseq Patent Sequence Database, Accession No. 97P-W3810, citing: WO 9741230 A2 dated Nov. 6, 1997; WO 97-EP2217 dated Apr. 30, 1997; DE 96-19617312 dated Apr. 30, 1996; “Search record pertaining to human CX3C chemokine”.
James U. Bowie et al., Science, 247: 1306-1310, Mar. 16, 1990. “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions”.
Claude Daniel et al., Virology, 202:540-549, 1994. “Mapping of Linear Antigenic Sites on the S Glycoprotein of a Neutropic Murine Coronavirus with Synthetic Peptides: A Combination of Nine Prediction Algorithms Fails to Identify Relevant Epitopes and Peptide Immunogenicity Is Drastically Influenced by the Nature of the Protein Carrier”.
C. Frommel et al., J. Mol. Evol., 21:233-257, 1985. “An Estimate on the Effect of Point Mutation and Natural Selection on the Rate of Amino Acid Replacement in Proteins”.
David G. George et al., Macromolecular Sequencing and Synthesis, David H. Schlesinger, Ed., Chapter 12, pp. 127-149, Alan R. Liss, Inc.: New York 1988. “Current Methods In Sequence Comparison and Analysis”.
Minoru Kanehisa, Nucleic Acids Research, 12(1):203-213, 1984. “Use of statistical criteria for screening potential homologies in nucleic acid sequences”.
J. Thomas Ngo et al., The Protein Folding Problem and Tertiary Structure Prediction, K. Mertz, Jr. and S. Le Grand, Eds., Chapter 14, pp. 491-495, Birkhauser: Boston 1994, “Computational Complexity, Protein Structure prediction and the Levinthal Paradox”.
G. Opdenakker et al., GenBank, Accession Nos. X72308 & S57464, Jul. 25, 1994. Definition: “H. sapiensMCP-3 mRNA for monocyte chemotactic protein-3”.
Sambrook, et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Chapters 9 and 11, CSHL: Cold Spring Harbor, New York, 1989.
Mikayama et al., Pr
Bacon Kevin R.
Bazan Fernando J.
Hardiman Gerard T.
Rossi Devora L.
Schall Thomas P.
Mertz Prema
Schering Corporation
LandOfFree
Methods of treating inflammation using mammalian CX 3 C... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating inflammation using mammalian CX 3 C..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating inflammation using mammalian CX 3 C... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4008725